Johan A Aarli

Summary

Country: Norway

Publications

  1. ncbi Neurology in sub-Saharan Africa: a challenge for World Federation of Neurology
    Johan A Aarli
    University of Bergen, Institutt for nevrologi, Haukeland Sykehus, Bergen, Norway
    Neurology 69:1715-8. 2007
  2. ncbi Chapter 41: the history of neurology in Scandinavia
    Johan A Aarli
    Department of Neurology, Haukeland University Hospital, Bergen, Norway
    Handb Clin Neurol 95:657-66. 2010
  3. ncbi Myasthenia gravis in the elderly: Is it different?
    Johan A Aarli
    Department of Neurology, University of Bergen, Bergen, Norway
    Ann N Y Acad Sci 1132:238-43. 2008
  4. ncbi Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis
    Fredrik Romi
    Department of Neurology, Haukeland University Hospital, N 5021 Bergen, Norway
    Ann N Y Acad Sci 998:481-90. 2003
  5. ncbi The role of complement in myasthenia gravis: serological evidence of complement consumption in vivo
    Fredrik Romi
    Department of Neurology, Haukeland University Hospital, Bergen N 5021, Norway
    J Neuroimmunol 158:191-4. 2005
  6. ncbi Myasthenia gravis in individuals over 40
    Johan A Aarli
    Department of Neurology, University of Bergen, Bergen, Norway
    Ann N Y Acad Sci 998:424-31. 2003
  7. ncbi Myasthenia gravis: a review of available treatment approaches
    Nils Erik Gilhus
    Department of Clinical Medicine, University of Bergen, 5020 Bergen, Norway
    Autoimmune Dis 2011:847393. 2011
  8. ncbi Neurological effects of deep diving
    Marit Grønning
    National Centre for Hyperbaric and Diving Medicine, Department of Occupational Medicine, Haukeland University Hospital, N 5021 Bergen, Norway
    J Neurol Sci 304:17-21. 2011
  9. ncbi Pathogenesis of myositis and myasthenia associated with titin and ryanodine receptor antibodies
    Geir Olve Skeie
    Department of Neurology, University of Bergen, Bergen, Norway
    Ann N Y Acad Sci 998:343-50. 2003
  10. ncbi Detection of viral sequences in archival spinal cords from fatal cases of poliomyelitis in 1951-1952
    Tiina Rekand
    Department of Neurology, Haukeland University Hospital, N 5020 Bergen, Norway
    J Virol Methods 114:91-6. 2003

Collaborators

Detail Information

Publications17

  1. ncbi Neurology in sub-Saharan Africa: a challenge for World Federation of Neurology
    Johan A Aarli
    University of Bergen, Institutt for nevrologi, Haukeland Sykehus, Bergen, Norway
    Neurology 69:1715-8. 2007
  2. ncbi Chapter 41: the history of neurology in Scandinavia
    Johan A Aarli
    Department of Neurology, Haukeland University Hospital, Bergen, Norway
    Handb Clin Neurol 95:657-66. 2010
    ....
  3. ncbi Myasthenia gravis in the elderly: Is it different?
    Johan A Aarli
    Department of Neurology, University of Bergen, Bergen, Norway
    Ann N Y Acad Sci 1132:238-43. 2008
    ..Titin antibodies in MG patients seem to be associated with a higher frequency of DR7 antigen and a decrease of DR3 antigen. The antibody response in MG may therefore be influenced by the genetic background...
  4. ncbi Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis
    Fredrik Romi
    Department of Neurology, Haukeland University Hospital, N 5021 Bergen, Norway
    Ann N Y Acad Sci 998:481-90. 2003
    ..Thymectomy should always be considered shortly after MG onset in early-onset MG patients and might only be considered in late-onset patients who have early-onset-like immunological characteristics...
  5. ncbi The role of complement in myasthenia gravis: serological evidence of complement consumption in vivo
    Fredrik Romi
    Department of Neurology, Haukeland University Hospital, Bergen N 5021, Norway
    J Neuroimmunol 158:191-4. 2005
    ..These antibodies are capable of complement activation in vitro. The involvement of the complement system should cause consumption of complement components such as C3 and C4 in vivo...
  6. ncbi Myasthenia gravis in individuals over 40
    Johan A Aarli
    Department of Neurology, University of Bergen, Bergen, Norway
    Ann N Y Acad Sci 998:424-31. 2003
    ..Late-onset, nonthymomatous MG comprises two subgroups, one corresponding to delayed early onset and one immunologically similar to that seen in patients with MG and thymoma...
  7. ncbi Myasthenia gravis: a review of available treatment approaches
    Nils Erik Gilhus
    Department of Clinical Medicine, University of Bergen, 5020 Bergen, Norway
    Autoimmune Dis 2011:847393. 2011
    ..MG pathogenesis is known in detail, but the immune therapy is still surprisingly unspecific, without a pin-pointed attack on the defined disease-inducing antigen-antibody reaction being available...
  8. ncbi Neurological effects of deep diving
    Marit Grønning
    National Centre for Hyperbaric and Diving Medicine, Department of Occupational Medicine, Haukeland University Hospital, N 5021 Bergen, Norway
    J Neurol Sci 304:17-21. 2011
    ..Prospective clinical studies with sufficient power and sensitivity are needed to solve this very important issue...
  9. ncbi Pathogenesis of myositis and myasthenia associated with titin and ryanodine receptor antibodies
    Geir Olve Skeie
    Department of Neurology, University of Bergen, Bergen, Norway
    Ann N Y Acad Sci 998:343-50. 2003
    ..However, so far, there is no direct evidence that antibodies against the intracellular antigens RyR and titin are pathogenic in vivo...
  10. ncbi Detection of viral sequences in archival spinal cords from fatal cases of poliomyelitis in 1951-1952
    Tiina Rekand
    Department of Neurology, Haukeland University Hospital, N 5020 Bergen, Norway
    J Virol Methods 114:91-6. 2003
    ..The sequences from the 2C region of poliovirus were rather conserved while those in the 5'-untranslated region were variable. The developed method should be suitable also for other genetic studies of old archival material...
  11. ncbi Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules
    Fredrik Romi
    Department of Neurology, Haukeland University Hospital, 5021, Bergen, Norway
    J Neuroimmunol 128:82-9. 2002
    ..In all cases, there is an overexpression of muscle-like epitopes and costimulatory molecules indicating that the T-cell autoimmunization is actively promoted by the pathogenic microenvironment inside the thymoma...
  12. ncbi Role of cytokines in neurological disorders
    Johan A Aarli
    Department of Neurology, University of Bergen, Norway
    Curr Med Chem 10:1931-7. 2003
    ..Studies of patients with epilepsy and animals with experimentally induced seizures indicate that cytokines may also influence the electrophysiological properties of neurons...
  13. ncbi WHO/WFN Survey of neurological services: a worldwide perspective
    Aleksandar Janca
    School of Psychiatry and Clinical Neurosciences, University of Western Australia, Perth, Australia
    J Neurol Sci 247:29-34. 2006
    ..who.int/mental_health/neurology/ ...
  14. ncbi The wind of change
    Johan A Aarli
    Arch Neurol 64:1694-5. 2007
  15. ncbi Thymectomy for myasthenia gravis: evaluation requires controlled prospective studies
    Alfred Jaretzki
    Ann Thorac Surg 76:1-3. 2003
  16. ncbi Preoperative preparation of patients with myasthenia gravis forestalls postoperative respiratory complications after thymectomy
    Alfred Jaretzki
    Ann Thorac Surg 75:1068; author reply 1069. 2003
  17. ncbi [Thymectomy and muscle antibodies in myasthenia gravis]
    Fredrik Romi
    Nevrologisk avdeling, Haukeland Universitetssykehus, 5021 Bergen
    Tidsskr Nor Laegeforen 124:629-31. 2004
    ..Thymectomy as a treatment for myasthenia gravis (MG) is widely carried out as there is good clinical evidence for post-thymectomy improvement in younger MG patients...